AI assistant
Sending…
CYTOKINETICS INC — Director's Dealing 2025
Mar 18, 2025
30870_dirs_2025-03-17_89e3e831-e267-4d29-ae31-3686a5deba89.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2025-03-17
Reporting Person: Callos Andrew (EVP, Chief Commercial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-03-17 | Common Stock | S | 2775 | $44.38 | Disposed | 34888 | Direct |
Footnotes
F1: Sell to cover transaction in connection with the vesting of restricted stock units.
More from CYTOKINETICS INC
Regulatory Filings
2026
May 27
Regulatory Filings
2026
May 27
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 5
Annual Report
2026
Apr 17
Proxy Solicitation & Information Statement
2026
Apr 17
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18